Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press2710.17650/1726-9776-2014-10-1-82-87CLINICAL CASEКЛИНИЧЕСКИЙ СЛУЧАЙTHE ATYPICAL SITE OF URETERAL METASTASIS IN A PATIENT WITH CASTRATION-REFRACTORY PROSTATE CANCER. A CLINICAL CASE AND A REVIEW OF LITERATUREНЕТИПИЧНАЯ ЛОКАЛИЗАЦИЯ МЕТАСТАЗА В МОЧЕТОЧНИКЕ У БОЛЬНОГО КАСТРАЦИОННО-РЕФРАКТЕРНЫМ РАКОМ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ. КЛИНИЧЕСКИЙ СЛУЧАЙ И ОБЗОР ЛИТЕРАТУРЫAlekseevB. Ya.АлексеевБ. Я.
Russian Federation
byalekseev@mail.ruNyushkoK. M.НюшкоК. М.
Russian Federation
byalekseev@mail.ruKalpinskyA. S.КалпинскийА. С.
Russian Federation
byalekseev@mail.ruVorobyevN. V.ВоробьевН. В.
Russian Federation
byalekseev@mail.ruGolovashchenkoM. P.ГоловащенкоМ. П.
Russian Federation
byalekseev@mail.ruKaprinA. D.КапринА. Д.
Russian Federation
byalekseev@mail.ruP. A. Herzen Moscow Oncology Research InstituteМНИОИ им. П. А. ГерценаP. A. Herzen Moscow Oncology Research Institute3003201410182872407201424072014https://oncourology.abvpress.ru/oncur/article/view/27

Prostate cancer (PC) is one of the most burning problems of modern urologic oncology because the incidence of this pathology remains high now. Castration-refractory PC (CRPC) is an extremely heterogeneous disease whose prognosis is largely determined by a number of factors, including the number and site of distant metastases. In the patients with CRPC, distant metastases are verified with the highest frequency in the bones, lymph nodes, and lung. Atypical metastatic involvement cases are rarely observed in patients with CRPC. The paper gives a review of literature and describes a clinical case of the atypical site of metastasis in a patient with CRPC.

 

Рак предстательной железы (РПЖ) является одной из наиболее актуальных проблем современной онкоурологии по причине сохраняющихся в настоящее время высоких показателей заболеваемости данной патологией. Кастрационно-рефрактерный РПЖ (КРРПЖ)  –  чрезвычайно гетерогенное заболевание, прогноз которого во многом определяется рядом факторов, в том числе количеством и локализацией отдаленных метастазов. С наибольшей частотой отдаленные метастазы у больных КРРПЖ верифицируют в костях, лимфатических узлах, легких. Нетипичные случаи метастатического поражения у больных КРРПЖ наблюдаются редко. В статье представлен обзор литературы и описание клинического случая нетипичной локализации метастаза у больного КРРПЖ

castration-refractory prostate cancerdistant metastasesureteral metastatic involvementatypical site of metastasesкастрационно-рефрактерный рак предстательной железыотдаленные метастазыметастатическое поражение мочеточниканетипичная локализация метастазов1. Состояние онкологической помощи населению России в 2011 году. Под ред. В. И. Чиссова, В. В. Старинского, Г. В. Петровой. М., 2012.Состояние онкологической помощи населению России в 2011 году. Под ред. В. И. Чиссова, В. В. Старинского, Г. В. Петровой. М., 2012.2. Aggarwal R., Halabi S., Kelly W. K. et al. The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance). Cancer 2013;119(20):3636–43.Aggarwal R., Halabi S., Kelly W. K. et al. The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance). Cancer 2013;119(20):3636–43.3. Pond G. R., Sonpavde G., de Wit R. et al. The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2013 Oct 5; pii: S0302–2838(13)01011–7.Pond G. R., Sonpavde G., de Wit R. et al. The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2013 Oct 5; pii: S0302–2838(13)01011–7.4. Heath E. I., Heilbrun L. K., Li J. et al. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res 2010;2(4):402 – 11.Heath E. I., Heilbrun L. K., Li J. et al. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res 2010;2(4):402 – 11.5. Hatzoglou V., Patel G. V., Morris M. J. et al. Brain Metastases from Prostate Cancer: An 11-Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis. J Neuroimaging 2012 Dec 28; doi: 10.1111 / j. 1552–6569.Hatzoglou V., Patel G. V., Morris M. J. et al. Brain Metastases from Prostate Cancer: An 11-Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis. J Neuroimaging 2012 Dec 28; doi: 10.1111 / j. 1552–6569.6. Gandaglia G., Abdollah F., Schiffmann J. et al. Distribution of metastatic sites in patients with prostate cancer: A population-based analysis. Prostate. 2013 Oct 16; doi: 10.1002 / pros. 22742.Gandaglia G., Abdollah F., Schiffmann J. et al. Distribution of metastatic sites in patients with prostate cancer: A population-based analysis. Prostate. 2013 Oct 16; doi: 10.1002 / pros. 22742.7. Albsoul N. M., Obeidat F. N., Hadidy A. M. et al. Isolated multiple bilateral thyroid metastases from prostatic adenocarcinoma: case report and literature review. Endocr Pathol 2013;24(1):36 – 9.Albsoul N. M., Obeidat F. N., Hadidy A. M. et al. Isolated multiple bilateral thyroid metastases from prostatic adenocarcinoma: case report and literature review. Endocr Pathol 2013;24(1):36 – 9.8. Petts G., Rashid T., Hrouda D. et al. Tumour-to-tumour metastases: prostate carcinoma metastasising to a renal oncocytoma. BMJ Case Rep 2013 Jan 9;2013; pii: bcr2012007366. doi: 10.1136 / bcr-2012–007366.Petts G., Rashid T., Hrouda D. et al. Tumour-to-tumour metastases: prostate carcinoma metastasising to a renal oncocytoma. BMJ Case Rep 2013 Jan 9;2013; pii: bcr2012007366. doi: 10.1136 / bcr-2012–007366.9. Hatzoglou V., Patel G. V., Morris M. J. et al. Brain Metastases from Prostate Cancer: An 11-Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis. J Neuroimaging 2012 Dec 28; doi: 10.1111 / j. 1552–6569.2012.00767. x.Hatzoglou V., Patel G. V., Morris M. J. et al. Brain Metastases from Prostate Cancer: An 11-Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis. J Neuroimaging 2012 Dec 28; doi: 10.1111 / j. 1552–6569.2012.00767. x.10. Petcu E. B., Gonzalez-Serva A., Wright R. G. et al. Prostate carcinoma metastatic to the skin as an extrammamary Paget's disease. Diagn Pathol 2012;7:106; doi: 10.1186 / 1746-1596-7-106.Petcu E. B., Gonzalez-Serva A., Wright R. G. et al. Prostate carcinoma metastatic to the skin as an extrammamary Paget's disease. Diagn Pathol 2012;7:106; doi: 10.1186 / 1746-1596-7-106.11. Manach Q., Phй V., Parra J et al. Ureteral metastasis of prostatic adenocarcinoma: Case report and literature review. Prog Uro 2013;23 (16):1443–8.Manach Q., Phй V., Parra J et al. Ureteral metastasis of prostatic adenocarcinoma: Case report and literature review. Prog Uro 2013;23 (16):1443–8.12. Schneider S., Popp D., Denzinger S. et al. A Rare Location of Metastasis from Prostate Cancer: Hydronephrosis Associated with Ureteral Metastasis. Adv Urol 2012: 656023. September 7; doi: 10.1155 / 2012 / 656023.Schneider S., Popp D., Denzinger S. et al. A Rare Location of Metastasis from Prostate Cancer: Hydronephrosis Associated with Ureteral Metastasis. Adv Urol 2012: 656023. September 7; doi: 10.1155 / 2012 / 656023.13. Petit J., Lesueur P., Petit J. et al. Ureteral metastases from prostatic cancers. 2 cases. Review of the literature. J Urol Nephrol (Paris) 1978;84(10α11):705–13.Petit J., Lesueur P., Petit J. et al. Ureteral metastases from prostatic cancers. 2 cases. Review of the literature. J Urol Nephrol (Paris) 1978;84(10α11):705–13.14. Zollinger R. W. 2nd, Wise H. A. 2nd, Clausen K. P. An unusual presentation of intrinsic ureteral obstruction secondary to carcinoma of the prostate: a case report. J Urol 1981;125(1):132–3.Zollinger R. W. 2nd, Wise H. A. 2nd, Clausen K. P. An unusual presentation of intrinsic ureteral obstruction secondary to carcinoma of the prostate: a case report. J Urol 1981;125(1):132–3.15. Cortadellas R., Prieto V., Castellanos R. et al. Ureteral metastasis of prostatic adenocarcinoma. Review of the literature. Arch Esp Urol 1989;42(1):19–22.Cortadellas R., Prieto V., Castellanos R. et al. Ureteral metastasis of prostatic adenocarcinoma. Review of the literature. Arch Esp Urol 1989;42(1):19–22.16. Hulse C. A., O'Neill T. K. Adenocarcinoma of the prostate metastatic to the ureter with an associated ureteral stone. J Urol 1989;142 (5):1312–3.Hulse C. A., O'Neill T. K. Adenocarcinoma of the prostate metastatic to the ureter with an associated ureteral stone. J Urol 1989;142 (5):1312–3.17. Haddad F. S. Metastases to the ureter. Review of the world literature, and three new case reports. J Med Liban 1999;47(4): 265–71.Haddad F. S. Metastases to the ureter. Review of the world literature, and three new case reports. J Med Liban 1999;47(4): 265–71.18. Yonneau L., Lebret T., Hervй J. M. et al. Isolated ureteral metastasis of prostatic adenocarcinoma. Apropos of a case. Prog Urol 1999;9(1):118–21.Yonneau L., Lebret T., Hervй J. M. et al. Isolated ureteral metastasis of prostatic adenocarcinoma. Apropos of a case. Prog Urol 1999;9(1):118–21.